The proteolytic airway environment associated with pneumonia acts as a barrier for treatment with anti-infective antibodies
- Resource Type
- Article
- Source
- In
European Journal of Pharmaceutics and Biopharmaceutics February 2024 195 - Subject
- Language
- ISSN
- 0939-6411